OLIMEL Trademark

Trademark Overview

On Tuesday, November 20, 2007, a trademark application was filed for OLIMEL with the United States Patent and Trademark Office. The USPTO has given the OLIMEL trademark a serial number of 77333947. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 15, 2011. This trademark is owned by BAXTER INTERNATIONAL INC.. The OLIMEL trademark is filed in the Pharmaceutical Products category with the following description:

PARENTERAL PHARMACEUTICALS, NAMELY, INTRAVENOUS NUTRITIONAL SOLUTIONS SOLD IN MIXING CONTAINERS HAVING TWO OR MORE CHAMBERS
olimel

General Information

Serial Number77333947
Word MarkOLIMEL
Filing DateTuesday, November 20, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 15, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 22, 2008

Trademark Statements

Goods and ServicesPARENTERAL PHARMACEUTICALS, NAMELY, INTRAVENOUS NUTRITIONAL SOLUTIONS SOLD IN MIXING CONTAINERS HAVING TWO OR MORE CHAMBERS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 26, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBAXTER INTERNATIONAL INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDEERFIELD, IL 60015
Party NameBAXTER INTERNATIONAL INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDEERFIELD, IL 60015

Trademark Events

Event DateEvent Description
Monday, August 15, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 15, 2011ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 6, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2011EXTENSION 5 GRANTED
Thursday, December 30, 2010EXTENSION 5 FILED
Thursday, December 30, 2010TEAS EXTENSION RECEIVED
Saturday, July 3, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 2, 2010EXTENSION 4 GRANTED
Tuesday, June 22, 2010EXTENSION 4 FILED
Tuesday, June 22, 2010TEAS EXTENSION RECEIVED
Monday, January 11, 2010EXTENSION 3 GRANTED
Monday, December 28, 2009EXTENSION 3 FILED
Monday, December 28, 2009TEAS EXTENSION RECEIVED
Thursday, July 2, 2009EXTENSION 2 GRANTED
Tuesday, June 30, 2009EXTENSION 2 FILED
Tuesday, June 30, 2009TEAS EXTENSION RECEIVED
Thursday, January 15, 2009EXTENSION 1 GRANTED
Tuesday, December 30, 2008EXTENSION 1 FILED
Thursday, January 15, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 30, 2008TEAS EXTENSION RECEIVED
Tuesday, July 15, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 22, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 2, 2008NOTICE OF PUBLICATION
Wednesday, March 19, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 19, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 19, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, March 19, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2008EXAMINERS AMENDMENT -WRITTEN
Monday, March 17, 2008PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, March 7, 2008WITHDRAWN FROM PUB - OG REVIEW QUERY
Sunday, February 24, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, February 24, 2008ASSIGNED TO LIE
Thursday, February 14, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 12, 2008ASSIGNED TO EXAMINER
Monday, November 26, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

olimel containers mixing having more chambers sold solutions pharmaceuticals namely intravenous